Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Articles

p38 Mitogen-Activated Protein Kinase Promotes Cell Survival in Response to DNA Damage but Is Not Required for the G2 DNA Damage Checkpoint in Human Cancer Cells

Mark S. Phong, Robert D. Van Horn, Shuyu Li, Gregory Tucker-Kellogg, Uttam Surana, Xiang S. Ye
Mark S. Phong
1Lilly Singapore Center for Drug Discovery, Pte Ltd. (Eli Lilly & Company), Singapore, Republic of Singapore
5Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert D. Van Horn
2Cancer Research Division, Lilly Research Labs, Lilly Corporate Center, Eli Lilly & Company, Indianapolis, Indiana 46285
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuyu Li
3Translational Science, Lilly Research Labs, Lilly Corporate Center, Eli Lilly & Company, Indianapolis, Indiana 46285
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory Tucker-Kellogg
1Lilly Singapore Center for Drug Discovery, Pte Ltd. (Eli Lilly & Company), Singapore, Republic of Singapore
6Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Republic of Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uttam Surana
4Institute of Molecular and Cell Biology, Agency of Science, Technology, and Research, Singapore, Republic of Singapore
5Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang S. Ye
2Cancer Research Division, Lilly Research Labs, Lilly Corporate Center, Eli Lilly & Company, Indianapolis, Indiana 46285
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ye_xiang_s@lilly.com
DOI: 10.1128/MCB.00949-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    DNA damage induces G2 arrest and activates p38 MAPK and Chk1 pathways. (A) Cell cycle profiles of control HeLa cells or HeLa cells treated with 160 nM adriamycin, 500 J/m2 UV irradiation, or 0.01% MMS for 24 h. (B and C) Western blot analysis of the activation of p38α and phosphorylation of its substrate MK2 in unsynchronized HeLa cells treated with increasing doses of UV irradiation, with 10 μg/ml anisomycin treatment as a positive control (B) and with 0.01% MMS for various time intervals for up to 10 h (C). (D) Synchronized HeLa cells treated with 160 nM adriamycin 5 h after release from a second thymidine block. Cell cycle progression and p38 activation were analyzed by flow cytometry and Western blotting at the time points indicated after release. (E to G) DNA damage in synchronized cells. HeLa cells were synchronized at G1 by serum starvation (E), at G1/S by double-thymidine block (F), and at G2 with the CDK1 inhibitor RO-3306 (G) and were then released into 0.01% MMS-containing fresh medium. The activation of p38 and Chk1 kinases was followed by Western blotting at the time intervals indicated.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Inhibition of Chk1 but not p38 abrogates the G2 DNA damage checkpoint in HeLa cells. (A) Mitotic index of unsynchronized HeLa cells that were pretreated for 20 h with adriamycin prior to the addition of 320 nM p38 inhibitor (p38i) or 1.25μM Chk1 inhibitor (Chk1i) and 150 nM nocodazole. Mitotic indexes were quantified by using the high-content/high-throughput Acumen Explorer for cells expressing phospho-histone H3 at the time points indicated after inhibitor treatment. (B) Western blot analysis of double-thymidine-synchronized HeLa cells treated with various kinase inhibitors in the presence of 160 nM adriamycin and 150 nM nocodazole 20 h after release from the thymidine block. Lane 1, double-thymidine-treated cells; lane 2, untreated HeLa cells; lanes 3 to 9, synchronized cells treated with adriamycin; lane 3, adriamycin alone; lane 4, adriamycin plus 320 nM p38i; lane 5, adriamycin plus 2 μM MK2 inhibitor (MK2i); lane 6, adriamycin plus 1.25 μM Chk1 inhibitor; lane 7, adriamycin plus 6 mM caffeine; lane 8, adriamycin plus 1.25 μM Chk1 inhibitor and 320 nM p38i; lane 9, adriamycin plus 6 mM caffeine and 320 nM p38i. (C) Western blot analysis of the relationship between p38 activation/inactivation and the DNA damage response. Thymidine-synchronized HeLa cells were released into 0.01% MMS, and cells were analyzed at the times indicated. (D) Mitotic index of unsynchronized HeLa cells treated with 500 J/m2 UV-B irradiation for 20 h prior to the addition of 320 nM p38i or 1.25 μM Chk1 inhibitor in the presence of 150 nM nocodazole (Noc). (E) Western blot of HeLa cells treated with 1,000 J/m2 UV-B and the indicated doses of p38i, MK2 inhibitor, or Chk1 inhibitor 24 h after kinase inhibitor treatment.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Inhibition of Chk1 but not p38 by small-molecule kinase inhibitors or RNAi abrogates the UV-induced G2 DNA damage checkpoint. (A) Western blot analysis of the response of cells after the inactivation of Chk1, p38, or MK2 by two specific and validated siRNA oligonucleotides directed against each gene to adriamycin. (B) Mitotic index plot of HeLa cells with p38 or Chk1 knockdown and treated with 160 nM adriamycin or 500 J/m2 UV for 24 h. (C) p53-dependent abrogation of the G2 DNA damage checkpoint by Chk1 inhibition. A549, U2OS, and Calu-6 cancer cells were treated with 160 nM adriamycin for 24 h before the addition of kinase inhibitors (320 nM p38i or 1.25 μM Chk1 inhibitor). Mitotic indexes were determined at 3 and 24 h after the addition of kinase inhibitors. (D and E) MK2 is not required for G2 DNA damage checkpoint control following UV-C irradiation. U2OS cells treated with green fluorescent protein (GFP) or MK2 (MAPKAP kinase 2) siRNA were irradiated with 20 J/m2 of UV-C as described previously (31) and then placed into 50 ng/ml nocodazole-containing medium for an additional 16 h. Target protein knockdown, DNA content, and phospho-histone H3 of cells were analyzed by Western blotting (D) and flow cytometry (E).

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Nongenotoxic activation of p38 with anisomycin does not impede entry into mitosis in HeLa cells. (A) Mitotic index (phospho-histone H3) of HeLa cells synchronized with the CDK1 inhibitor RO-3306 in the presence or absence of 2 μg/ml anisomycin. (B) Western blot for the p38 activation of HeLa cells synchronized with the CDK1 inhibitor RO-3306 by 2 μg/ml anisomycin.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Inactivation of p38 inhibits immediate-early response and antiapoptotic pathways in TNF-α-treated Calu-6 cells. (A) Cluster analysis of genes differentially expressed 1 h after TNF-α treatment and effect of 320 nM p38i LY479754 on these expression changes. Gene expression values are represented by colors, with red and green indicating high and low expressions, respectively. (B) Box plots of TNF-α response of immediate-early response genes and members of apoptosis pathway component genes at the 1-h time point in the presence or absence of p38 kinase inhibitor. (C) Western blots of p38 activation, apoptosis, and cell death/survival pathway protein expression in Calu-6 cells treated with TNF-α in the presence of 320 nM p38i LY479754. (D) Apoptotic index (percentage of cells expressing cleaved PARP) of Calu-6 cells treated with 25 ng/ml TNF-α and various concentrations of p38i using an Acumen Explorer high-content imaging assay. CTRL, control with no treatment.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Inhibition of p38 MAPK sensitizes cells to adriamycin and induces cell death. (A) Apoptosis index (percentage of cells expressing cleaved caspase 3) of HeLa cells treated with increasing doses of the p38i LY479754 in the presence of 160 nM adriamycin for 48 h. (B) Western blot for apoptosis of HeLa cells treated with siRNA targeting p38α, MK2, or Chk1 in the presence or absence of 160 nM adriamycin for 48 h. NS-si, nonspecific/scramble siRNA. (C) Western blot analysis of synchronized A549 cells by serum starvation for 48 h after treatment with 1 μM p38i LY479754 in the presence of DNA damage induced by 160 nM adriamycin for 48 h. (D) Western blot of A549 cells treated with 0.01% MMS and 1 μM p38i LY479754 for 48 h. (E) Apoptosis induced by p38 inhibition in the presence of DNA damage is associated with G2 arrest. The apoptosis index and cell cycle state were determined for A549 cells treated with 160 nM adriamycin and 1 μM p38i LY479754 using Acumen Explorer.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    New model for a novel role of p38 MAPK in the DNA damage response in cancer cells. DNA damage elicits the activation of cell cycle checkpoint, DNA repair, and cell survival signaling pathways. In response to DNA damage, the Chk1-mediated G2 DNA damage checkpoint is activated to prevent entry into mitosis with damaged DNA, whereas the p38-mediated cell survival pathway is activated to keep cells alive. Together, these two pathways afford cell the time to repair DNA damage and ultimately to allow recovery from DNA damage.

Additional Files

  • Figures
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 - Tables S1 and S2 (Gene expression changes in response to TNF-α stimulation [S1] and TNF-α and/or LY479754 [S2])
      PDF file, 192K.
PreviousNext
Back to top
Download PDF
Citation Tools
p38 Mitogen-Activated Protein Kinase Promotes Cell Survival in Response to DNA Damage but Is Not Required for the G2 DNA Damage Checkpoint in Human Cancer Cells
Mark S. Phong, Robert D. Van Horn, Shuyu Li, Gregory Tucker-Kellogg, Uttam Surana, Xiang S. Ye
Molecular and Cellular Biology Jul 2010, 30 (15) 3816-3826; DOI: 10.1128/MCB.00949-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
p38 Mitogen-Activated Protein Kinase Promotes Cell Survival in Response to DNA Damage but Is Not Required for the G2 DNA Damage Checkpoint in Human Cancer Cells
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
p38 Mitogen-Activated Protein Kinase Promotes Cell Survival in Response to DNA Damage but Is Not Required for the G2 DNA Damage Checkpoint in Human Cancer Cells
Mark S. Phong, Robert D. Van Horn, Shuyu Li, Gregory Tucker-Kellogg, Uttam Surana, Xiang S. Ye
Molecular and Cellular Biology Jul 2010, 30 (15) 3816-3826; DOI: 10.1128/MCB.00949-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

DNA damage
p38 Mitogen-Activated Protein Kinases

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549